Lansoprazole PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Lansoprazole PCD pharma franchise company offering 7 formulations across capsules, tablets and injection. Manufactured under WHO-GMP certified standards, this range gives franchise partners a dependable proton-pump-inhibitor line for the very high-volume acid-peptic disease segment.

What is Lansoprazole?

Lansoprazole is a proton pump inhibitor (PPI). It irreversibly binds and blocks the H+/K+ ATPase enzyme (the proton pump) in the gastric parietal cells, producing a profound and long-lasting reduction in stomach acid secretion. This potent acid suppression allows healing of acid-related mucosal damage and control of reflux symptoms. Learn more on PubChem.

Therapeutic Applications of Lansoprazole

Lansoprazole is used for gastro-oesophageal reflux disease (GERD), gastric and duodenal ulcers, erosive oesophagitis, as part of Helicobacter pylori eradication regimens, and for hypersecretory conditions such as Zollinger-Ellison syndrome. It is prescribed by gastroenterologists, physicians and surgeons, with the injection used in hospitalised patients.

Why Lansoprazole is a High-Potential Molecule for Distributors

Acid-peptic disorders are among the most commonly treated conditions in India, giving proton pump inhibitors enormous and consistent prescription volumes across primary and specialist care. With oral and injectable options covering 7 formulations, lansoprazole lets a distributor serve both retail and hospital channels, anchoring a fast-moving gastro portfolio with dependable repeat demand.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.

References

1. PubChem – Lansoprazole Compound Summary, U.S. National Library of Medicine
2. PubMed – Clinical literature on Lansoprazole